米国のアルツハイマー病診断市場は、2024年に35億3,000万ドルと評価され、2025年から2030年にかけてCAGR 10.6%で成長すると予想されます。この成長は、アルツハイマー病の有病率の上昇と、早期かつ正確な診断への注目の高まりによって推進されています。米国疾病管理予防センター(CDC)によると、2024年には米国で約670万人の高齢者がアルツハイマー病を患っており、その数は2060年までにほぼ倍増すると予測されています。この疾患の有病率の増加により、政府や民間の医療機関は、PETイメージング、脳脊髄液バイオマーカー、血液ベースの診断などの高度な診断技術に多額の投資を行うようになりました。
目次
Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definition
1.3. Information Procurement
1.3.1. Purchased Database
1.3.2. GVR’s Internal Database
1.3.3. Secondary Sources and Third-Party Perspectives
1.3.4. Primary Research
1.4. Information Analysis
1.4.1. Data Analysis Models
1.5. Market Formulation and Data Visualization
1.6. Data Validation and Publishing
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. U.S. Alzheimer’s Disease Diagnostics Market Variables, Trends and Scope
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.2.3. Industry Challenge
3.3. Industry Analysis Tools
3.3.1. PORTER’s Analysis
3.3.1.1. Bargaining power of the suppliers
3.3.1.2. Bargaining power of the buyers
3.3.1.3. Threats of substitution
3.3.1.4. Threats from new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic and social landscape
3.3.2.3. Technological landscape
Chapter 4. U.S. Alzheimer’s Disease Diagnostics Market: Diagnostic Technique Estimates and Trend Analysis
4.1. U.S. Alzheimer’s Disease Diagnostics Market, By Diagnostic Technique: Key Takeaways
4.2. Diagnostic Technique Movement Analysis and Market Share, 2024 and 2030
4.3. Market Estimates and Forecasts, By Diagnostic Technique, 2018 - 2030 (USD Million)
4.3.1. Biomarkers
4.3.1.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.1.2. CSF Biomarkers
4.3.1.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.1.3. Blood-Based Biomarkers
4.3.1.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.2. Imaging Diagnostic Techniques
4.3.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.3. Genetic Testing
4.3.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.4. Cognitive Assessment Tests
4.3.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. U.S. Alzheimer’s Disease Diagnostics Market: Type Estimates and Trend Analysis
5.1. U.S. Alzheimer’s Disease Diagnostics Market, By Type: Key Takeaways
5.2. Type Movement Analysis and Market Share, 2024 and 2030
5.3. Market Estimates and Forecasts, By Type, 2018 - 2030 (USD Million)
5.3.1. Triage
5.3.1.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.2. Diagnosis
5.3.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.3. Screening
5.3.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. U.S. Alzheimer’s Disease Diagnostics Market: End Use Estimates and Trend Analysis
6.1. U.S. Alzheimer’s Disease Diagnostics Market, By End Use: Key Takeaways
6.2. End Use Movement Analysis and Market Share, 2024 and 2030
6.3. Market Estimates and Forecasts, By End Use, 2018 - 2030 (USD Million)
6.3.1. Hospitals
6.3.1.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.2. Diagnostic Laboratories
6.3.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.3. Academic and Research Institutes
6.3.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Competitive Landscape
7.1. Company Categorization
7.2. Company Market Positioning
7.3. Company Heat Map Analysis
7.4. Company Profiles/Listing
7.4.1. GE HealthCare
7.4.1.1. Company Overview
7.4.1.2. Financial Performance
7.4.1.3. Diagnostic Technique Portfolio
7.4.1.4. Recent Developments/ Strategic Initiatives
7.4.2. Siemens Healthineers AG
7.4.2.1. Company Overview
7.4.2.2. Financial Performance
7.4.2.3. Diagnostic Technique Portfolio
7.4.2.4. Recent Developments/ Strategic Initiatives
7.4.3. Canon Medical Systems Corporation
7.4.3.1. Company Overview
7.4.3.2. Financial Performance
7.4.3.3. Diagnostic Technique Portfolio
7.4.3.4. Recent Developments/ Strategic Initiatives
7.4.4. Cerveau Technologies, Inc.
7.4.4.1. Company Overview
7.4.4.2. Financial Performance
7.4.4.3. Diagnostic Technique Portfolio
7.4.4.4. Recent Developments/ Strategic Initiatives
7.4.5. Neurovision Imaging, Inc.
7.4.5.1. Company Overview
7.4.5.2. Financial Performance
7.4.5.3. Diagnostic Technique Portfolio
7.4.5.4. Recent Developments/ Strategic Initiatives
7.4.6. Thermo Fisher Scientific Inc.
7.4.6.1. Company Overview
7.4.6.2. Financial Performance
7.4.6.3. Diagnostic Technique Portfolio
7.4.6.4. Recent Developments/ Strategic Initiatives
7.4.7. Bio-Rad Laboratories, Inc.
7.4.7.1. Company Overview
7.4.7.2. Financial Performance
7.4.7.3. Diagnostic Technique Portfolio
7.4.7.4. Recent Developments/ Strategic Initiatives
7.4.8. Quanterix Corporation
7.4.8.1. Company Overview
7.4.8.2. Financial Performance
7.4.8.3. Diagnostic Technique Portfolio
7.4.8.4. Recent Developments/ Strategic Initiatives
7.4.9. Alzheon Inc.
7.4.9.1. Company Overview
7.4.9.2. Financial Performance
7.4.9.3. Diagnostic Technique Portfolio
7.4.9.4. Recent Developments/ Strategic Initiatives
7.4.10. NanoSomiX, Inc.
7.4.10.1. Company Overview
7.4.10.2. Financial Performance
7.4.10.3. Diagnostic Technique Portfolio
7.4.10.4. Recent Developments/ Strategic Initiatives
7.4.11. DiamiR Biosciences
7.4.11.1. Company Overview
7.4.11.2. Financial Performance
7.4.11.3. Diagnostic Technique Portfolio
7.4.11.4. Recent Developments/ Strategic Initiatives
List of Tables
Table 1 List of abbrevation
Table 2 U.S. alzheimer’s disease diagnostics market: key market driver analysis
Table 3 U.S. alzheimer’s disease diagnostics market: Key market restraint analysis
Table 4 U.S. alzheimer’s disease diagnostics market estimates and forecast, by diagnostic technique (USD Million)
Table 5 U.S. alzheimer’s disease diagnostics market estimates and forecast, by type (USD Million)
Table 6 U.S. alzheimer’s disease diagnostics market estimates and forecast, by end use (USD Million)
Table 7 Recent developments and impact analysis by key market participants
Table 8 Company heat map analysis, 2024
Table 9 Companies implementing key strategies
List of Figures
Fig. 1 U.S. Alzheimer’s disease diagnostics market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value chain-based sizing and forecasting
Fig. 7 Parent market analysis
Fig. 8 Market formulation and validation
Fig. 9 U.S. Alzheimer’s disease diagnostics market snapshot
Fig. 10 U.S. Alzheimer’s disease diagnostics market segment snapshot
Fig. 11 U.S. Alzheimer’s disease diagnostics market competitive landscape snapshot
Fig. 12 Market research process
Fig. 13 Market driver relevance analysis (Current and future impact)
Fig. 14 Market restraint relevance analysis (Current and future impact)
Fig. 15 U.S. Alzheimer’s disease diagnostics market: Diagnostic technique outlook key takeaways (USD Million)
Fig. 16 U.S. Alzheimer’s disease diagnostics market: Diagnostic technique movement analysis 2024 & 2030 (USD Million)
Fig. 17 Biomarkers market estimates & forecasts, 2018 - 2030 (USD Million)
Fig. 18 Imaging diagnostic Techniques market estimates & forecasts, 2018 - 2030 (USD Million)
Fig. 19 Genetic testing market estimates & forecasts, 2018 - 2030 (USD Million)
Fig. 20 Cognitive assessment tests market estimates & forecasts, 2018 - 2030 (USD Million)
Fig. 21 U.S. Alzheimer’s Disease Diagnostics market: Type outlook key takeaways (USD Million)
Fig. 22 U.S. Alzheimer’s Disease Diagnostics market: Type movement analysis 2024 & 2030 (USD Million)
Fig. 23 Triage market estimates & forecasts, 2018 - 2030 (USD Million)
Fig. 24 Diagnosis market estimates & forecasts, 2018 - 2030 (USD Million)
Fig. 25 Screening market estimates & forecasts, 2018 - 2030 (USD Million)
Fig. 26 U.S. alzheimer’s disease diagnostics market: End Use outlook key takeaways (USD Million)
Fig. 27 U.S. alzheimer’s disease diagnostics market: End Use movement analysis 2024 & 2030 (USD Million)
Fig. 28 Hospitals market estimates & forecasts, 2018 - 2030 (USD Million)
Fig. 29 Diagnostic Laboratories market estimates & forecasts, 2018 - 2030 (USD Million)
Fig. 30 Academic and Research Institutes market estimates & forecasts, 2018 - 2030 (USD Million)
Fig. 31 Strategy framework
Fig. 32 Company categorization
